Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yishen Tian

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Micromachines|July 8, 2023
Microfluidic Chips: Emerging Technologies for Adoptive Cell ImmunotherapyYishen Tian, Rong Hu, Guangshi Du, et al.
Chembiochem : a European Journal of Chemical Biology|January 23, 2018
A Modular Nanoswitch for Mix-and-Detect Protein Assay Based on Binding-Induced Cascade Dissociation of Kissing ComplexYishen Tian, Shanshan Zhang, Li Wang, et al.
Nanomaterials (Basel, Switzerland)|January 24, 2019
Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor ScreeningYishen Tian, Lijie Hao, Chao Wang, et al.
ACS Sensors|June 16, 2018
Affinity Binding-Induced Hg<sup>2+</sup> Release and Quantum Dot Doping for General, Label-Free, and Homogenous Fluorescence Protein AssayYishen Tian, Chen Xin, Shuang Liu, et al.
Lab on a Chip|October 22, 2021
Personalized gel-droplet monocyte vaccines for cancer immunotherapyYishen Tian, Chunmiao Xu, Jiao Feng, et al.
Biofabrication|March 4, 2024
Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategiesYishen Tian, Wei Chen, Guangshi Du, et al.
Scientific Reports|May 6, 2026
Lactate reprograms PGE2 metabolism via GPR81 inhibits COX2 to relieved psoriasisYajun An, Bin Wang, Jing He, et al.
Neoplasia (New York, N.Y.)|April 22, 2025
An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunityLi Xiao, Rong Hu, Wei Chen, et al.
Journal of Neuroinflammation|December 5, 2025
VSIG2 as a novel immunosuppressive ligand interacts with Nectin-2 to regulate T cell responsesXianbin Wang, Rong Hu, Kezhu Chen, et al.
Materials Today. Bio|March 3, 2025
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapyYishen Tian, Jingxuan Li, Na Yang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Micromachines|July 8, 2023
Microfluidic Chips: Emerging Technologies for Adoptive Cell ImmunotherapyYishen Tian, Rong Hu, Guangshi Du, et al.
Chembiochem : a European Journal of Chemical Biology|January 23, 2018
A Modular Nanoswitch for Mix-and-Detect Protein Assay Based on Binding-Induced Cascade Dissociation of Kissing ComplexYishen Tian, Shanshan Zhang, Li Wang, et al.
Nanomaterials (Basel, Switzerland)|January 24, 2019
Quantum Dot Doping-Induced Photoluminescence for Facile, Label-Free, and Sensitive Pyrophosphatase Activity Assay and Inhibitor ScreeningYishen Tian, Lijie Hao, Chao Wang, et al.
ACS Sensors|June 16, 2018
Affinity Binding-Induced Hg<sup>2+</sup> Release and Quantum Dot Doping for General, Label-Free, and Homogenous Fluorescence Protein AssayYishen Tian, Chen Xin, Shuang Liu, et al.
Lab on a Chip|October 22, 2021
Personalized gel-droplet monocyte vaccines for cancer immunotherapyYishen Tian, Chunmiao Xu, Jiao Feng, et al.
Biofabrication|March 4, 2024
Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategiesYishen Tian, Wei Chen, Guangshi Du, et al.
Scientific Reports|May 6, 2026
Lactate reprograms PGE2 metabolism via GPR81 inhibits COX2 to relieved psoriasisYajun An, Bin Wang, Jing He, et al.
Neoplasia (New York, N.Y.)|April 22, 2025
An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunityLi Xiao, Rong Hu, Wei Chen, et al.
Journal of Neuroinflammation|December 5, 2025
VSIG2 as a novel immunosuppressive ligand interacts with Nectin-2 to regulate T cell responsesXianbin Wang, Rong Hu, Kezhu Chen, et al.
Materials Today. Bio|March 3, 2025
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapyYishen Tian, Jingxuan Li, Na Yang, et al.
Pageof 1